If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEland Oil & Gas Regulatory News (ELA)

  • There is currently no data for ELA

Directorate Change

11 Jul 2016 07:01

RNS Number : 7470D
Eland Oil & Gas PLC
11 July 2016
 

11 July 2016

 

Eland Oil & Gas PLC

("Eland" or the "Company")

 

Directorate Change

 

 

Eland Oil & Gas PLC (AIM: ELA), an oil & gas production and development company operating in West Africa with an initial focus on Nigeria, today announces the appointment of Henry Obi to the Board as a Non-Executive Director representing Helios Natural Resources a significant shareholder in Eland. Henry will replace Richard Norris who has been Helios Natural Resources' representative on the Board since September 2014. The Board thanks Richard for his valuable contribution and wishes him well for the future.

 

Henry Obi has over 15 years' experience in private equity sector and is currently a Partner and Chief Operating Officer at Helios Investment Partners LLP ("Helios") where he responsible for its operations and serves on Helios' Equity and Credit Investment Committees. Prior to joining Helios in 2006, Henry was a Partner at Aureos Advisers Limited where he was responsible for monitoring the performance of the firm's funds in Africa and Central America and their compliance with investment policy. Prior to Aureos, Henry worked for Actis, CDC Group Plc and Dynegy, a US energy trader.

 

Henry holds a BSc. Architecture and MSc. Architecture from University of Nigeria, a B.Arch. from University of Nottingham and an MBA in Finance from the London Business School. He sits on the Boards of Maris Capital Limited and the Africa Venture Capital Association. He also served as Chairman of the Africa Regional Advisory Council of Emerging Market Private Equity Association. He received Private Equity Africa's Outstanding Leadership Award in 2014 for his commitment to advancing the cause of private equity in Africa.

 

 

Henry Awele Obi's (age 53) current directorships and partnerships are as follows:

 

Advance American Style Inc.

African Private Equity & Venture Capital Association

Helios Credit Genpar, Limited

Helios Investment Partners, LLP

HIP Africa Ltd.

HIP Equity I, L.P.

HIP Equity II. L.P.

HIP Equity III, L.P.

Interswitch Limited

Maris Capital Limited

 

 

Mr Obi's directorships in the last five years are as follows

 

Royal Exchange Microfinance Bank Limited

 

Henry Obi indirectly holds 10,043 voting ordinary shares in Eland through HIP Equity II, L.P. ("HIP Equity") (representing 0.01% of the current voting ordinary share capital of the Company) and a further 1,150 non-voting ordinary shares indirectly through Helios Natural Resources Ltd whose only asset is shares in Eland. Any monetisation of the indirect stake is at the sole discretion of Helios Natural Resources Ltd.

 

Helios Natural Resources Limited holds 54,963,815 voting ordinary shares in the Company, including those held on behalf of Mr Obi as described above, representing 29.5% of the current voting ordinary share capital of the Company. Helios Natural Resources Ltd also hold 6,296,815 non-voting ordinary shares, including those held on behalf of Mr Obi.

 

 

For further information:

 

Eland Oil & Gas PLC (+44 (0)1224 737300)

www.elandoilandgas.com

George Maxwell, CEO

Olivier Serra, CFO

Finlay Thomson, IR

 

Canaccord Genuity Limited (+44 (0)20 7523 8000)

Henry Fitzgerald O'Connor

Nilesh Patel

 

Panmure Gordon (UK) Limited (+44 (0)20 7886 2500)

Adam James / Atholl Tweedie

Tom Salvesen

 

Camarco (+44 (0) 203 757 4980)

Billy Clegg / Georgia Mann

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAKMGMNLGLGVZM
Date   Source Headline
15th Nov 20062:50 pmRNSAnnual Report
25th Oct 20062:18 pmRNSBlocklisting Interim Review
25th Oct 20067:30 amBUSElan Reports Third Quarter 2006 Financial Results
24th Oct 20061:00 pmBUSTYSABRI(R) Maintained Remission in Patients with Moderate-to-Severe Crohn's Disease Treated for Longer Than Two Years According to Data Presented This Week
18th Oct 20068:42 amRNSHolding in Company
10th Oct 20067:00 amBUSNotice of Results
6th Oct 20062:07 pmBUSNew Pharmacoeconomic Data on TYSABRI(R) Demonstrate Significant Reduction in Steroid Use and Hospitalizations in Patients with Multiple Sclerosis
4th Oct 20061:00 pmBUSHealth Canada Grants Approval of TYSABRI(TM) (natalizumab) for the Treatment of Multiple Sclerosis Following Priority Review
29th Sep 20062:00 pmBUSNew Data Presented at ECTRIMS Congress Show TYSABRI(R) Has Sustained Effect on Relapse Rate in Multiple Sclerosis Patients Treated for up to Three Years
11th Sep 200611:57 amRNSFinancial Statements
9th Aug 20068:58 amRNSHolding in Company
2nd Aug 20065:26 pmRNSDirector/PDMR Shareholding
2nd Aug 200612:12 pmRNSHolding in Company
29th Jun 200612:32 pmRNSHolding in Company
21st Jun 200610:01 amRNSHolding in Company
15th Jun 20068:20 amRNSHolding in Company
7th Jun 20068:02 amRNSFurther re Appointment
1st Jun 200611:58 amRNSHolding in Company
25th May 20063:31 pmRNSHolding in Companies
25th May 200612:37 pmRNSHolding in Company
19th May 20065:51 pmRNSDirectors/PDMR Shareholding
19th May 200610:56 amRNSHolding in Company
17th May 200612:16 pmRNSHolding in Company
12th May 20061:45 pmRNSDirector/PDMR Shareholding
24th Apr 200611:36 amRNSHolding in Company
20th Apr 20064:44 pmRNSDocument Availability
19th Apr 20063:30 pmRNSHolding in Company
13th Apr 200612:51 pmRNSHolding in Company
13th Apr 200612:04 pmRNSAnnual Information Update
10th Apr 200612:42 pmRNSBrochure of Particulars
3rd Apr 20063:39 pmRNSBrochure of Particulars
13th Mar 200611:47 amRNSHoldings in Company
10th Mar 20063:24 pmRNSDirector/PDMR Shareholding
9th Mar 20067:30 amRNSRestoration of Listing
9th Mar 20067:01 amRNSOL Notice - Restoration
7th Mar 20061:00 pmRNSSuspension - Elan Corp Plc
7th Mar 20061:00 pmRNSOL Notice - Suspension
15th Feb 200610:15 amRNSBrochure of Particulars
10th Feb 20064:55 pmRNSDirector/PDMR Shareholding
9th Feb 20065:32 pmRNSDirector/PDMR Shareholding
9th Feb 20063:54 pmRNSHolding in Company
8th Feb 200610:56 amRNSDirector/PDMR Shareholding
3rd Feb 20069:58 amRNSDirector/PDMR Shareholding
25th Jan 200611:19 amRNSHolding in Company
9th Dec 20054:02 pmRNSDirector/PDMR Shareholding
17th Nov 20052:31 pmRNSRE:Director/PDMR Shareholding
1st Nov 20055:32 pmRNSDirector/PDMR Shareholding
22nd Sep 20059:43 amRNSRe: Brochure of Particulars
23rd Aug 20055:12 pmRNSDirector/PDMR Shareholding
21st Jun 200511:32 amRNSBrochure of Particulars

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.